Jean-Marie BOURHIS | Assistant Professor | PhD | Viral Replication Machinery | Research profile
An expert's insight on FLASH radiotherapy: Prof. Jean Bourhis, Chief or Radio-Oncology at CHUV - YouTube
Contre le cancer, des rayons très prometteurs | 24 heures
The FLASH Effect: Establishing a Path to Human Clinical Trials
Jean Bourhis - Advisor at Nanobiotix | The Org
Scientific Advisory Board | Nanobiotix
Debiopharm on Twitter: "Pr. Jean Bourhis, Head of Radio-Oncology at CHUV Lausanne and the lead of the study, shares his thoughts about IAP antagonist and chemo-radio-sensitizer #Debio1143 for #headandneckcancer #ESMO2019 https://t.co/Z3TXbHbpWe" /
Jean Bourhis - Bannalec 1916 | Aerosteles
Particle physics pushing cancer treatment boundaries | eNCA
Jean Bourhis - Directeur des financements Groupe - Groupe REALITES | LinkedIn
Jean-Pierre LE BOURHIS | Senior Researcher | PhD in political science | French National Centre for Scientific Research, Paris | CNRS | CRAPE - Arenes | Research profile
Kährs Group Honored By Saint-Gobain for Corporate Social Responsibility | Wood Floor Business
Jean Bourhis — Wikipédia
The FLASH Effect: Establishing a Path to Human Clinical Trials
GORTEC: Cisplatin chemoradiation plus debio 1143 in patients with locally advanced head and neck squamous cell carcinoma - ecancer
JEAN BOURHIS - ONCOBELL
Prof. Jean Bourhis - Fond'action contre le cancer
ITV du Pr Jean Bourhis - Les traitements des cancers ORL localement avancés. (février 2016) - YouTube
Dr. Bourhis on the Rationale to Explore Debio 1143 in Head and Neck Cancer
Jean Bourhis – Chief of Radiation Oncology Service – CHUV / Centre hospitalier universitaire vaudois | LinkedIn
Scientific Advisory Board | Nanobiotix
Trois Concarnois médaillés dans l'Ordre national du Mérite maritime - Concarneau - Le Télégramme
Bourhis Jean – SWISS CANCER CENTER Léman
Dr. Bourhis on the OS Benefit of Xevinapant Plus Chemoradiotherapy in HNSCC
Jean Bourhis - Bannalec 1916 | Aerosteles
